About Intercept Pharmaceuticals

What does Intercept Pharmaceuticals do?

Intercept Pharmaceuticals is a provider of small molecule drugs and therapeutics for chronic fibrotic and metabolic diseases, including INT-747, an FXR modulating agent for chronic autoimmune liver diseases.

Who are Intercept Pharmaceuticals's competitors?

Intercept Pharmaceuticals's competitors and similar companies include Affymax, PhaseBio, Nimbus Therapeutics, Nexus BioPharma, and Clarus Therapeutics.

Where is Intercept Pharmaceuticals headquartered?

Intercept Pharmaceuticals is headquartered in United States.

How many employees does Intercept Pharmaceuticals have?

Intercept Pharmaceuticals has 1,000 employees 🔒.

When was Intercept Pharmaceuticals founded?

Intercept Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Intercept Pharmaceuticals in?

Intercept Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Intercept Pharmaceuticals

Who are the top strategic acquirers in Intercept Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Intercept Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Intercept Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Intercept Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Intercept Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Intercept Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Intercept Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Intercept Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Intercept Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Intercept Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Intercept Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Intercept Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Intercept Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Intercept Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Intercept Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Intercept Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Intercept Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Intercept Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Intercept Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Intercept Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.